Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
24 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/25/2952677/0/en/Junshi-Biosciences-Announces-European-Commission-Approval-for-Marketing-of-Toripalimab.html
30 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/31/2938774/0/en/Junshi-Biosciences-Announces-2024-Interim-Financial-Results-and-Provides-Corporate-Updates.html
12 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/12/2928508/0/en/Junshi-Biosciences-Announces-Acceptance-of-Supplemental-New-Drug-Application-for-Toripalimab-as-First-Line-Treatment-of-Unresectable-Metastatic-Melanoma.html
26 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/07/26/2919683/0/en/Junshi-Biosciences-Announces-Positive-Opinion-from-the-European-Medicines-Agency-s-CHMP-For-Toripalimab.html
17 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/07/18/2915001/0/en/Junshi-Biosciences-Announces-the-Acceptance-of-the-Supplemental-New-Drug-Application-for-Toripalimab-Combined-with-Bevacizumab-for-the-First-Line-Treatment-of-Advanced-Hepatocellul.html
25 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/25/2903696/0/en/Junshi-Biosciences-Announces-Approval-of-the-sNDA-for-Toripalimab-for-the-1st-Line-Treatment-of-Advanced-TNBC.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?